USFDA 483 to Laurus: Lapses in cleaning,
Laurus, Visakh was issued USFDA 483 with five (5) observations following USFDA inspection by investigators
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Laurus, Visakh was issued USFDA 483 with five (5) observations following USFDA inspection by investigators
Aarti Drugs API facility in Tarapur, India was inspected by USFDA investigators Rajeev R. Srivastava
Laurus, Visakh was issued USFDA 483 with five (5) observations following USFDA inspection by investigators